Importer of Controlled Substances Application: Wedgewood Village Pharmacy, LLC, 38099-38100 [2023-12434]
Download as PDF
<![CDATA[
38099
Federal Register / Vol. 88, No. 112 / Monday, June 12, 2023 / Notices
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Agri-Tech Producers LLC,
Columbia, SC; Breakwave Energy, San
Diego, CA; Excel Technologies,
Herndon, VA; Jupiter Intelligence, Inc.,
San Mateo, CA; Maplewell, Inc.,
Broomfield, CO; Metatomic, Inc.,
Greenville, SC; Oxford Global
Resources, Beverly, MA; Oxford
Villages, Inc., Palm Springs, FL;
Raytheon Technologies, Waltham, MA;
State University of New York, Albany,
NY; TMGCore, Plano, TX; Versar, Inc.,
Washington, DC; and Zyon Space,
Washington, DC, have been added as
parties to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and RISE intends
to file additional written notifications
disclosing all changes in membership.
On July 2, 2021, RISE filed its original
notification pursuant to section 6(a) of
the Act. The Department of Justice
published a notice in the Federal
Register pursuant to section 6(b) of the
Act on August 23, 2021 (86 FR 47155).
The last notification was filed with
the Department on January 11, 2023. A
notice was published in the Federal
Register pursuant to section 6(b) of the
Act on March 17, 2023 (88 FR 16460).
Suzanne Morris,
Deputy Director, Civil Enforcement
Operations, Antitrust Division.
BILLING CODE 4410–11–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1216]
Bulk Manufacturer of Controlled
Substances Application: Veranova,
L.P.
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Open Grid Alliance, Inc.
Notice is hereby given that, on March
28, 2023, pursuant to section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), Open Grid Alliance,
Inc. (‘‘OGA’’) has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Communications
Infrastructure Networks LTD (CIN),
London, UNITED KINGDOM;
Jkt 259001
PO 00000
Frm 00085
Fmt 4703
Sfmt 4703
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on May 5, 2023, Veranova,
L.P., 25 Patton Road, Pharmaceutical
Service, Devens, Maine 01434–3803,
applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
Controlled substance
Methamphetamine ..........
Methylphenidate .............
Nabilone .........................
Hydrocodone ..................
Levorphanol ....................
Thebaine .........................
Alfentanil .........................
Remifentanil ....................
Sufentanil ........................
Drug
code
Schedule
1100
1724
7379
9193
9220
9333
9737
9739
9740
II
II
II
II
II
II
II
II
II
The company plans to bulk
manufacture the listed controlled
substances in order to support the
manufacturing and analytical testing
activities at its other Drug Enforcement
Administration-registered
manufacturing facility. No other
activities for these drug codes are
authorized for this registration.
Matthew Strait,
Deputy Assistant Administrator.
Veranova, L.P. has applied to
be registered as a bulk manufacturer of
basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before August 11, 2023. Such
persons may also file a written request
for a hearing on the application on or
before August 11, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
SUMMARY:
DEPARTMENT OF JUSTICE
ddrumheller on DSK120RN23PROD with NOTICES1
[FR Doc. 2023–12505 Filed 6–9–23; 8:45 am]
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
BILLING CODE 4410–11–P
17:39 Jun 09, 2023
Suzanne Morris,
Deputy Director, Civil Enforcement
Operations, Antitrust Division.
AGENCY:
[FR Doc. 2023–12506 Filed 6–9–23; 8:45 am]
VerDate Sep<11>2014
Dragonfruit AI, Menlo Park, CA; PLAN
B Developpement Inc., Outremont,
CANADA; and SLEdge Consulting,
LTD., London, UNITED KINGDOM,
have been added as parties to this
venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and OGA intends
to file additional written notifications
disclosing all changes in membership.
On March 31, 2022, OGA filed its
original notification pursuant to section
6(a) of the Act. The Department of
Justice published a notice in the Federal
Register pursuant to section 6(b) of the
Act on May 12, 2022 (87 FR 29180).
The last notification was filed with
the Department on January 10, 2023. A
notice was published in the Federal
Register pursuant to section 6(b) of the
Act on March 17, 2023 (88 FR 16461).
[FR Doc. 2023–12433 Filed 6–9–23; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1217]
Importer of Controlled Substances
Application: Wedgewood Village
Pharmacy, LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Wedgewood Village
Pharmacy, LLC has applied to be
registered as an importer of basic
class(es) of controlled substance(s).
Refer to SUPPLEMENTARY INFORMATION
listed below for further drug
information.
SUMMARY:
E:\FR\FM\12JNN1.SGM
12JNN1
38100
Federal Register / Vol. 88, No. 112 / Monday, June 12, 2023 / Notices
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before July 12, 2023. Such persons
may also file a written request for a
hearing on the application on or before
July 12, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on May 3, 2023,
Wedgewood Village Pharmacy, LLC,
7631 East Indian School Road, Suite
201, Scottsdale, Arizona, 85251–3607
applied to be registered as an importer
of the following basic class(es) of
controlled substance(s):
DATES:
Controlled substance
ddrumheller on DSK120RN23PROD with NOTICES1
Etorphine HCl .................
Thiafentanil .....................
Drug
code
Schedule
9059
9729
II
II
The company plans to import the
listed controlled substances for
distribution to their customers. No other
activities for these drug codes are
authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
VerDate Sep<11>2014
17:39 Jun 09, 2023
Jkt 259001
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023–12434 Filed 6–9–23; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
[OMB Number 1140–0099]
Agency Information Collection
Activities; Proposed eCollection
eComments Requested; Extension of a
Previously Approved Collection; ATF
Adjunct Instructor Data Form
Bureau of Alcohol, Tobacco,
Firearms and Explosives, Department of
Justice.
ACTION: 60-Day notice.
AGENCY:
The Bureau of Alcohol,
Tobacco, Firearms and Explosives
(ATF), Department of Justice (DOJ), will
be submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 60 days until
August 11, 2023.
FOR FURTHER INFORMATION CONTACT: If
you have additional comments,
especially on the estimated public
burden or associated response time,
suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact:
Elaine Wilson Harrison (ATF), Training
and Accreditation Branch, either by
mail at Building 681, 1131 Chapel
Crossing Rd., Brunswick, GA 31520,
email at elaine.wilson@atf.gov, or
telephone at 912–258–6445.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the Bureau of Justice
Statistics, including whether the
information will have practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
SUMMARY:
PO 00000
Frm 00086
Fmt 4703
Sfmt 4703
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information to be collected can be
enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Abstract: ATF uses the adjunct
instructor data form to collect
information from prospective non-ATF
instructors. Prospects may be from other
Federal, State, and Local agencies as
well as educational institutions—
colleges, universities and privately
owned businesses.
Overview of This Information
Collection
1. Type of Information Collection:
Extension of a previously approved
collection.
2. The Title of the Form/Collection:
ATF Adjunct Instructor Data Form.
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
Form number: ATF Form 6140.3.
Component: Training and
Accreditation Branch.
4. Affected public who will be asked
or required to respond, as well as the
obligation to respond: Affected Public:
Individuals or households, Business or
other for-profit, Not-for-profit
institutions, and State, Local or Tribal
Government. The obligation to respond
is required to obtain/retain a benefit.
5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: An estimated 20 respondents
will utilize the form annually, and it
will take each respondent
approximately 30 minutes to complete
their responses.
6. An estimate of the total annual
burden (in hours) associated with the
collection: The estimated annual public
burden associated with this collection is
10 hours, which is equal to 20 (total
respondents) * 1 (# of response per
respondent) * .5 (30 minutes).
7. An estimate of the total annual cost
burden associated with the collection, if
applicable: $0.
E:\FR\FM\12JNN1.SGM
12JNN1
]]>Agencies
[Federal Register Volume 88, Number 112 (Monday, June 12, 2023)]
[Notices]
[Pages 38099-38100]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-12434]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1217]
Importer of Controlled Substances Application: Wedgewood Village
Pharmacy, LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Wedgewood Village Pharmacy, LLC has applied to be registered
as an importer of basic class(es) of controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed below for further drug information.
[[Page 38100]]
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
July 12, 2023. Such persons may also file a written request for a
hearing on the application on or before July 12, 2023.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment. All
requests for a hearing must be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152. All requests for a hearing should also be
sent to: Drug Enforcement Administration, Attn: Administrator, 8701
Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on May 3, 2023, Wedgewood Village Pharmacy, LLC, 7631
East Indian School Road, Suite 201, Scottsdale, Arizona, 85251-3607
applied to be registered as an importer of the following basic
class(es) of controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Etorphine HCl.......................... 9059 II
Thiafentanil........................... 9729 II
------------------------------------------------------------------------
The company plans to import the listed controlled substances for
distribution to their customers. No other activities for these drug
codes are authorized for this registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration-approved or non-approved finished
dosage forms for commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023-12434 Filed 6-9-23; 8:45 am]
BILLING CODE 4410-09-P
